The Pfizer and Moderna vaccines against SARS-CoV-2 produce strong antibody responses in people with HIV and similar antibody...
A Brazilian man who last summer had no evidence of remaining HIV after more than 15 months off antiretroviral therapy once again had detectable viral load...
A therapeutic vaccine allowed some people with HIV to interrupt treatment for at least 22 weeks and maintain very low viral load, Dr Beatriz Mothe of...
High initiation and persistence on pre-exposure prophylaxis (PrEP) has been documented in pregnant women in Cape Town, South Africa, with 91% of those offered PrEP...
Widely available ART in rural South Africa has led to dramatic decreases in AIDS-related mortality over the last few years. A new qualitative study has revealed...
A study published in Nature on Wednesday has used novel gene-sequencing probes to investigate exactly how the one in 200 people with HIV who are so-called...